Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction

Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction

Detalhes bibliográficos
Principais autores:	Muthusamy, A, Roy, D, Elker, D, Quiroga, I, Lale, R, Smith, J, Sujendran, V, Sinha, S, Vaidya, A, Friend, P
Formato:	Journal article
Publicado em:	2007

Registros relacionados

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
por: Muthusamy, A, et al.
Publicado em: (2008)

Alemtuzumab induction and steroid free immunosupprssion in pancreas transplantation.
por: Muthusamy, A, et al.
Publicado em: (2007)

ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION
por: Muthusamy, A, et al.
Publicado em: (2011)

Complex arterial reconstruction for pancreas transplantation in recipients with advanced arteriosclerosis.
por: Muthusamy, A, et al.
Publicado em: (2008)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
por: Flechner, S, et al.
Publicado em: (2005)

Thromboelastography directed anticoagulation in pancreas transplantation
por: Muthusamy, A, et al.
Publicado em: (2007)

Campath Induction and Steroid Avoidance in Pancreas Transplantation - A Single Centre Experience in 231 Patients.
por: Muthusamy, A, et al.
Publicado em: (2009)

Simultaneous pancreas--kidney transplantation: to anticoagulate or not? Is that a question?
por: Vaidya, A, et al.
Publicado em: (2007)

PANCREAS ALLOGRAFT: IMPACT OF THE RETRIEVAL CENTRE ON THE UTILIZATION OF THE ORGAN
por: Rizzello, A, et al.
Publicado em: (2011)

SINGLE CENTRE EXPERIENCE WITH DCD PANCREAS TRANSPLANTATION
por: Muthusamy, A, et al.
Publicado em: (2011)

PANCREAS TRANSPLANTATION IN RECIPIENTS AGED >= 50 YEARS
por: Muthusamy, A, et al.
Publicado em: (2011)

Expanded criteria donors in pancreas transplantation: The Oxford experience
por: Muthusamy, A, et al.
Publicado em: (2009)

Revascularization of the gastro-epiploic artery in pancreas transplant.
por: Muthusamy, A, et al.
Publicado em: (2008)

Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients
por: Adam Kaplan, et al.
Publicado em: (2020-01-01)

Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients
por: Milena Elimelakh, et al.
Publicado em: (2007-08-01)

Clopidogrel-associated acute migratory arthritis following kidney-pancreas transplantation.
por: Muthusamy, A, et al.
Publicado em: (2006)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Martina Guthoff, et al.
Publicado em: (2020-05-01)

Value of Magnetic Resonance Angiography in Pancreas Transplantation.
por: Suh, N, et al.
Publicado em: (2009)

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
por: Brook, MO, et al.
Publicado em: (2024)

Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
por: Yuan-Yuan Liu, et al.
Publicado em: (2015-01-01)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
por: Plata-Munoz, J, et al.
Publicado em: (2009)

Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.
por: Trzonkowski, P, et al.
Publicado em: (2008)

Towards Steroid-Free Immunosuppression after Liver Transplantation
por: Victor M. Zaydfudim, et al.
Publicado em: (2016-07-01)

Simultaneous pancreas kidney transplantation in the HIV-positive patient.
por: Akhtar, M, et al.
Publicado em: (2011)

Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.
por: Alberto Benazzo, et al.
Publicado em: (2019-01-01)

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.
por: Tonghai Xing, et al.
Publicado em: (2013-01-01)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
por: Haynes, R, et al.
Publicado em: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
por: Haynes, R, et al.
Publicado em: (2014)

Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.
por: Hester, J, et al.
Publicado em: (2011)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
por: PLOS ONE Editors
Publicado em: (2019-01-01)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
por: Watson, C, et al.
Publicado em: (2005)

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
por: Haynes, R, et al.
Publicado em: (2014)

Pancreas transplantation
por: Knight, S, et al.
Publicado em: (2017)

Pancreas transplantation from non-heart beating donors in the United Kingdom
por: Muthusamy, A, et al.
Publicado em: (2009)

PANCREAS TRANSPLANTATION FROM NON-HEART BEATING DONORS IN THE UNITED KINGDOM
por: Muthusamy, A, et al.
Publicado em: (2009)

ANALYSIS OF RENAL FUNCTION AFTER SOLITARY PANCREAS TRANSPLANTATION: IS CNIs THE ONLY CULPRIT?
por: Chatzizacharias, N, et al.
Publicado em: (2011)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Masashi Furukawa, et al.
Publicado em: (2022-06-01)

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
por: Morgan, R, et al.
Publicado em: (2012)

Risk analysis for deterioration of renal function after pancreas alone transplant.
por: Chatzizacharias, N, et al.
Publicado em: (2012)

Pancreas transplantation: past, present, future
por: Dholakia, S, et al.
Publicado em: (2016)